Ceramat’s 3D‑Printed Grafts Put India on Global Medical Map with TDB-DST Support

Representative Image

In a significant stride toward strengthening India’s medical technology ecosystem, the Technology Development Board (TDB) under the Department of Science & Technology (DST) has extended financial assistance to Ceramat Private Limited, Palghar, Maharashtra, for the commercialisation of advanced 3D-printed patient-specific bone grafts.

The project, titled “Calcium Phosphate based Standard and Customized Patient Specific Grafts by 3D Printing via Digital Light Processing Technique and Extrusion-based Equipment”, aims to transform the way bone grafts are manufactured and delivered in India. By leveraging indigenously developed bioceramic materials and cutting-edge additive manufacturing technologies, Ceramat seeks to reduce dependence on imported medical products and establish India as a hub for personalised healthcare solutions.

Ceramat’s Vision for Indigenous Innovation

Ceramat makes special powders and ceramics (like hydroxyapatite and calcium phosphate) that are very similar to the minerals in real human bone. These materials are shaped into grafts — pieces doctors use to repair or replace damaged bone.

Instead of making generic grafts, Ceramat uses advanced 3D printers to create patient‑specific grafts that match the exact shape of someone’s bone. This means every graft can be custom‑fit, improving recovery and reducing complications.

Think of it like this: if you break a part of your bone, instead of using a “one‑size‑fits‑all” piece, doctors can now give you a graft that’s tailor‑made for your body.

Ceramat Private Limited was founded with a mission to develop and commercialise

 bio-ceramics and advanced ceramics that serve as high-quality import substitutes. Its portfolio includes biomaterials such as:

• Hydroxyapatite
• Beta-tricalcium phosphate
• Biphasic calcium phosphate
• Bioactive glass

These materials find applications across orthopaedics, oral care, cosmetics, and industrial sectors.

The Technology Behind Patient-Specific Grafts

The initiative integrates Digital Light Processing (DLP)-based 3D printing and extrusion-based 3D printing with indigenous calcium phosphate biomaterials. These complementary approaches will allow Ceramat to manufacture both standard and customised grafts, offering:

• Complex geometries that mimic natural bone structures
• Patient-specific designs for personalised medical care
• Enhanced flexibility in clinical applications

Aligning with Aatmanirbhar Bharat

The project is closely aligned with the government’s vision of Aatmanirbhar Bharat, focusing on advanced manufacturing and indigenous medical technology development. By reducing reliance on imported bioceramic and orthobiological products, the initiative will:

• Strengthen domestic supply chains
• Create opportunities for global market expansion
• Position India as a technology developer rather than just a consumer

Why It’s Globally Relevant

Ceramat’s work matters far beyond India. By producing advanced bone grafts locally, it reduces the country’s dependence on costly imports and makes treatment more affordable. At the same time, mastering patient‑specific 3D printing puts India in direct competition with global medical technology leaders.

This innovation reflects a broader shift in healthcare toward personalized solutions, where treatments are tailored to each individual rather than relying on generic options. Because the same techniques can be applied to dental implants, facial reconstruction, and even cosmetic surgery, Ceramat’s approach has the potential to influence multiple industries worldwide. In essence, India is positioning itself not just as a healthcare consumer, but as a healthcare innovator with solutions that can serve patients across the globe.

Conclusion

The collaboration between TDB-DST and Ceramat Private Limited marks a pivotal moment in India’s healthcare innovation journey. By combining indigenous biomaterials with state-of-the-art 3D printing, the project not only addresses critical medical needs but also reinforces India’s commitment to self-reliance, innovation, and global competitiveness in medical manufacturing.

Material	Application
Hydroxyapatite	Bone grafts, implants
Beta-tricalcium phosphate	Orthopaedics, oral care